Cascara sagrada laxatives
This article was originally published in The Tan Sheet
Executive Summary
FDA will not defer enforcement action against manufacturers of OTC laxatives containing cascara sagrada, agency states in Sept. 2 letter to Atlanta law firm Arnall Golden Gregory denying citizen petition. Decision barring laxatives containing ingredient from initial entry into interstate commerce as of Nov. 5, 2002 stands, FDA says. Agency reply follows recent letter to AHPA denying association's request to move cascara sagrada from Category III to Category I (1"The Tan Sheet" Aug. 4, 2003, p. 11)...
You may also be interested in...
Aloe, Cascara Sagrada Safety In Laxatives Still Needs Supporting Data – FDA
Data on aloe and cascara sagrada from the German Commission E monographs, World Health Organization reviews and the National Toxicology Program are insufficient to support the safety and efficacy of the ingredients in OTC laxatives, FDA concludes in a July 3 letter to the American Herbal Products Association
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.